Variant report

Variant	nsv525036
Chromosome Location	chr8:1910658-1918352
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr8:1911161-1911462	K562	blood:	n/a	n/a
2	CEBPB	chr8:1917852-1918103	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr8:1914751-1915120	IMR90	lung:	n/a	chr8:1914929-1914940 chr8:1914954-1914966 chr8:1914924-1914941 chr8:1914929-1914940
4	CEBPB	chr8:1917911-1918068	A549	lung:	n/a	n/a
5	CEBPB	chr8:1914793-1914975	K562	blood:	n/a	chr8:1914929-1914940 chr8:1914954-1914966 chr8:1914924-1914941 chr8:1914929-1914940
6	CEBPB	chr8:1917870-1918070	K562	blood:	n/a	n/a
7	CREB1	chr8:1916103-1916317	A549	lung:	n/a	chr8:1916249-1916262
8	CREB1	chr8:1916164-1916330	A549	lung:	n/a	chr8:1916249-1916262
9	FOXA1	chr8:1911369-1911679	T-47D	breast:	n/a	chr8:1911533-1911545
10	FOXA2	chr8:1916248-1916806	A549	lung:	n/a	n/a
11	FOXA2	chr8:1916162-1916884	A549	lung:	n/a	n/a
12	FOXP2	chr8:1914179-1914796	PFSK-1	brain:	n/a	n/a
13	FOXP2	chr8:1916353-1916623	PFSK-1	brain:	n/a	n/a
14	HA-E2F1	chr8:1911444-1912022	MCF-7	breast:	n/a	n/a
15	HDAC2	chr8:1911438-1911872	MCF-7	breast:	n/a	n/a
16	MAX	chr8:1916001-1916806	A549	lung:	n/a	n/a
17	MAX	chr8:1916415-1916619	H1-hESC	embryonic stem cell:	n/a	n/a
18	MAX	chr8:1918310-1918510	H1-hESC	embryonic stem cell:	n/a	chr8:1918397-1918407 chr8:1918395-1918408 chr8:1918397-1918407 chr8:1918396-1918405 chr8:1918397-1918406 chr8:1918395-1918410 chr8:1918395-1918408 chr8:1918396-1918407 chr8:1918397-1918406 chr8:1918396-1918407 chr8:1918398-1918405
19	MAX	chr8:1911120-1911538	NB4	blood:	n/a	chr8:1911380-1911389 chr8:1911379-1911390 chr8:1911381-1911388 chr8:1911379-1911390 chr8:1911380-1911390 chr8:1911380-1911389
20	MAX	chr8:1911207-1911669	MCF-7	breast:	n/a	chr8:1911380-1911389 chr8:1911379-1911390 chr8:1911381-1911388 chr8:1911379-1911390 chr8:1911380-1911390 chr8:1911380-1911389
21	MAX	chr8:1913318-1913345	NB4	blood:	n/a	n/a
22	MAZ	chr8:1916435-1916635	HepG2	liver:	n/a	n/a
23	MXI1	chr8:1916490-1916702	H1-hESC	embryonic stem cell:	n/a	n/a
24	MYC	chr8:1917965-1918021	MCF-7	breast:	n/a	n/a
25	MYC	chr8:1911255-1911268	MCF-7	breast:	n/a	n/a
26	MYC	chr8:1911253-1911452	NB4	blood:	n/a	chr8:1911380-1911389 chr8:1911379-1911390 chr8:1911381-1911388 chr8:1911379-1911390 chr8:1911380-1911390 chr8:1911380-1911389
27	MYC	chr8:1911123-1911250	MCF-7	breast:	n/a	n/a
28	MYC	chr8:1911102-1911515	MCF-7	breast:	n/a	chr8:1911380-1911389 chr8:1911379-1911390 chr8:1911381-1911388 chr8:1911379-1911390 chr8:1911380-1911390 chr8:1911380-1911389
29	MYC	chr8:1911197-1911458	MCF-7	breast:	n/a	chr8:1911380-1911389 chr8:1911379-1911390 chr8:1911381-1911388 chr8:1911379-1911390 chr8:1911380-1911390 chr8:1911380-1911389
30	NRF1	chr8:1912737-1912817	H1-hESC	embryonic stem cell:	n/a	n/a
31	POLR2A	chr8:1910769-1910782	MCF-7	breast:	n/a	n/a
32	POLR2A	chr8:1910720-1910748	MCF-7	breast:	n/a	n/a
33	POLR2A	chr8:1916430-1916565	A549	lung:	n/a	n/a
34	POLR2A	chr8:1916140-1916352	A549	lung:	n/a	n/a
35	POLR2A	chr8:1910854-1910886	MCF-7	breast:	n/a	n/a
36	POLR2A	chr8:1916367-1916593	A549	lung:	n/a	n/a
37	POLR2A	chr8:1917918-1918032	MCF-7	breast:	n/a	n/a
38	POLR2A	chr8:1917902-1918146	MCF-7	breast:	n/a	n/a
39	POLR2A	chr8:1911052-1911436	MCF-7	breast:	n/a	n/a
40	POLR2A	chr8:1915957-1916703	HCT-116	colon:	n/a	n/a
41	POLR2A	chr8:1916409-1916560	A549	lung:	n/a	n/a
42	POLR2A	chr8:1910789-1910793	MCF-7	breast:	n/a	n/a
43	POLR2A	chr8:1916169-1916322	A549	lung:	n/a	n/a
44	POLR2A	chr8:1916044-1916722	HCT-116	colon:	n/a	n/a
45	POLR2A	chr8:1910820-1910825	MCF-7	breast:	n/a	n/a
46	POLR2A	chr8:1911105-1911326	MCF-7	breast:	n/a	n/a
47	POLR2A	chr8:1910798-1910805	MCF-7	breast:	n/a	n/a
48	POLR2A	chr8:1916154-1916265	A549	lung:	n/a	n/a
49	REST	chr8:1916362-1916617	H1-hESC	embryonic stem cell:	n/a	n/a
50	REST	chr8:1916370-1916651	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:1913086-1913136	GM12878	blood:	n/a
2	chr8:1913086-1913136	GM12878	blood:	n/a
3	chr8:1915076-1915126	A549	lung:	n/a
4	chr8:1915004-1915054	HIPEpiC	eye:	n/a
5	chr8:1915076-1915126	HCPEpiC	choroid plexus:	n/a
6	chr8:1913132-1913182	HCM	heart:	n/a
7	chr8:1915076-1915126	Caco-2	colon:	n/a
8	chr8:1914991-1915041	MCF-7	breast:	n/a
9	chr8:1915004-1915054	HCF	heart:	n/a
10	chr8:1913086-1913136	HIPEpiC	eye:	n/a
11	chr8:1915076-1915126	HRPEpiC	eye:	n/a
12	chr8:1913132-1913182	AG10803	skin:	n/a
13	chr8:1914262-1914312	H1-hESC	embryonic stem cell:	embryo
14	chr8:1913132-1913182	AG09309	skin:	n/a
15	chr8:1914262-1914312	AG09319	gingival:	n/a
16	chr8:1915004-1915054	HUVEC	blood vessel:	n/a
17	chr8:1913269-1913319	NB4	blood:	n/a
18	chr8:1911588-1911638	HIPEpiC	eye:	n/a
19	chr8:1911588-1911638	SAEC	small airway:	n/a
20	chr8:1914262-1914312	HRPEpiC	eye:	n/a
21	chr8:1916285-1916335	HCPEpiC	choroid plexus:	n/a
22	chr8:1916285-1916335	Jurkat	blood:	n/a
23	chr8:1913269-1913319	HRCEpiC	kidney:	n/a
24	chr8:1916285-1916335	U87	brain:	n/a
25	chr8:1914991-1915041	ProgFib	skin:	n/a
26	chr8:1914262-1914312	PrEC	prostate:	n/a
27	chr8:1913269-1913319	CMK	blood:	n/a
28	chr8:1913269-1913319	SK-N-SH	brain:	n/a
29	chr8:1913424-1913474	SKMC	muscle:	n/a
30	chr8:1913269-1913319	AG04449	skin:	fetal
31	chr8:1915076-1915126	SK-N-SH_RA	brain:	n/a
32	chr8:1913086-1913136	A549	lung:	n/a
33	chr8:1914991-1915041	HEK293	kidney:	embryo
34	chr8:1914262-1914312	MCF-7	breast:	n/a
35	chr8:1913217-1913267	NB4	blood:	n/a
36	chr8:1914262-1914312	BE2_C	brain:	n/a
37	chr8:1911588-1911638	NB4	blood:	n/a
38	chr8:1913269-1913319	AoSMC	blood vessel:	n/a
39	chr8:1914262-1914312	NHDF-neo	bronchial:	n/a
40	chr8:1915004-1915054	HCM	heart:	n/a
41	chr8:1915076-1915126	CMK	blood:	n/a
42	chr8:1913217-1913267	GM12878	blood:	n/a
43	chr8:1914262-1914312	HCPEpiC	choroid plexus:	n/a
44	chr8:1913086-1913136	CMK	blood:	n/a
45	chr8:1913269-1913319	HRE	kidney:	n/a
46	chr8:1915004-1915054	NHBE	bronchial:	n/a
47	chr8:1913424-1913474	AG04450	lung:	fetal
48	chr8:1911588-1911638	PrEC	prostate:	n/a
49	chr8:1911588-1911638	GM12892	blood:	n/a
50	chr8:1911588-1911638	HCF	heart:	n/a

No.	Distal block	Cell Line	Cell type
1	chr8:1910618..1913298-chr8:1921170..1922936,2	MCF-7	breast:
2	chr8:1905928..1907788-chr8:1909949..1911807,2	MCF-7	breast:
3	chr8:1907491..1909196-chr8:1911477..1913920,2	K562	blood:
4	chr8:1911383..1914358-chr8:1918883..1921800,2	MCF-7	breast:
5	chr8:1877543..1880354-chr8:1915068..1917833,2	K562	blood:
6	chr8:1904438..1906943-chr8:1908364..1910920,2	K562	blood:

Variant related genes	Relation type
ENSG00000270988	TF binding region
KBTBD11-OT1	TF binding region
KBTBD11	TF binding region
ENSG00000270988	CpG island
KBTBD11-OT1	CpG island
KBTBD11	CpG island
ENSG00000253696	chromatin interactions
ENSG00000253764	chromatin interactions
ENSG00000176595	chromatin interactions

Extended variants
information (count: 496 )
Associated
traits (count: 115 )

Variant overlapped rSNPs/rCNVs (count:496 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs201539346	chr8:1910658-1910659	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs540597182	chr8:1910702-1910703	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs114463223	chr8:1910730-1910731	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs12334930	chr8:1910731-1910732	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs139735987	chr8:1910737-1910738	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs574048179	chr8:1910743-1910744	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs117401599	chr8:1910744-1910745	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs62476264	chr8:1910763-1910764	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs560720724	chr8:1910768-1910769	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs529490285	chr8:1910788-1910789	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs549057721	chr8:1910790-1910791	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs186111569	chr8:1910841-1910842	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs562699189	chr8:1910843-1910844	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs531312246	chr8:1910855-1910856	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs550936963	chr8:1910890-1910891	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs145306154	chr8:1910893-1910894	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs534079486	chr8:1910899-1910900	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs531788223	chr8:1910914-1910915	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs12677706	chr8:1910938-1910939	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs147182719	chr8:1910959-1910960	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs536100063	chr8:1910963-1910964	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs556403590	chr8:1910971-1910972	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs575762501	chr8:1910986-1910987	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs568857581	chr8:1910988-1910989	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs190821358	chr8:1910989-1910990	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs113313983	chr8:1910990-1910991	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs544738879	chr8:1910993-1910994	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs55724906	chr8:1911063-1911064	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs577985235	chr8:1911068-1911069	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs13268460	chr8:1911072-1911073	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs140511951	chr8:1911073-1911074	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs150009622	chr8:1911122-1911123	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs182284380	chr8:1911123-1911124	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs145283715	chr8:1911144-1911145	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs4446772	chr8:1911158-1911159	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs117359327	chr8:1911165-1911166	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs73550378	chr8:1911190-1911191	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs548671134	chr8:1911197-1911198	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs547662167	chr8:1911208-1911209	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs13269070	chr8:1911270-1911271	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs369239748	chr8:1911281-1911282	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs373515555	chr8:1911310-1911311	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs186636706	chr8:1911312-1911313	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs557694515	chr8:1911313-1911314	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs536551054	chr8:1911317-1911318	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs111620142	chr8:1911336-1911337	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs191579745	chr8:1911369-1911370	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs538325966	chr8:1911381-1911382	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs558311225	chr8:1911384-1911385	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs577965586	chr8:1911391-1911392	Active TSS Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:115)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Cancer	18840272	CNVD
Pilocytic astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
Ductal carcinoma	22052326	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Epilepsy	22083797	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Breast cancer	20932292	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Ependymoma	20639864	CNVD
Ovarian cancer	22355333	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:213 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:1890000-1911000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr8:1905600-1910800	Weak transcription	Gastric	stomach
3	chr8:1905600-1921000	Weak transcription	Aorta	Aorta
4	chr8:1905800-1916800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
5	chr8:1906000-1911200	Weak transcription	HMEC	breast
6	chr8:1906000-1914200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr8:1906400-1911200	Weak transcription	Psoas Muscle	Psoas
8	chr8:1906400-1911400	Weak transcription	Placenta Amnion	Placenta Amnion
9	chr8:1906600-1910800	Weak transcription	Brain Angular Gyrus	brain
10	chr8:1906600-1911000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
11	chr8:1906600-1911200	Weak transcription	H9 Cell Line	embryonic stem cell
12	chr8:1906600-1911200	Weak transcription	Brain Germinal Matrix	brain
13	chr8:1906600-1911400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
14	chr8:1906600-1914200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
15	chr8:1906600-1914200	Weak transcription	Colonic Mucosa	Colon
16	chr8:1906600-1914600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr8:1906600-1921000	Weak transcription	Right Ventricle	heart
18	chr8:1906800-1910800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr8:1906800-1910800	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
20	chr8:1907000-1911000	Weak transcription	HSMMtube	muscle
21	chr8:1907000-1911200	Weak transcription	HSMM	muscle
22	chr8:1907000-1914200	Weak transcription	Left Ventricle	heart
23	chr8:1907000-1914400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
24	chr8:1907200-1911000	Weak transcription	NHDF-Ad	bronchial
25	chr8:1907200-1911000	Weak transcription	Osteobl	bone
26	chr8:1907200-1912400	Weak transcription	Fetal Lung	lung
27	chr8:1907200-1916000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
28	chr8:1907400-1910800	Enhancers	Fetal Intestine Small	intestine
29	chr8:1908000-1912600	Enhancers	Fetal Muscle Leg	muscle
30	chr8:1908600-1911000	Weak transcription	Muscle Satellite Cultured Cells	--
31	chr8:1908600-1913800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr8:1908600-1915000	Weak transcription	Right Atrium	heart
33	chr8:1908600-1915600	Weak transcription	A549	lung
34	chr8:1908800-1914000	Weak transcription	Rectal Mucosa Donor 31	rectum
35	chr8:1909000-1913200	Weak transcription	Spleen	Spleen
36	chr8:1909000-1919000	Weak transcription	Fetal Kidney	kidney
37	chr8:1909200-1911000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr8:1909400-1912200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
39	chr8:1909400-1913800	Weak transcription	Duodenum Mucosa	Duodenum
40	chr8:1910000-1911600	Enhancers	Liver	Liver
41	chr8:1910000-1911800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr8:1910000-1914200	Weak transcription	Fetal Intestine Large	intestine
43	chr8:1910400-1915200	Bivalent Enhancer	Fetal Stomach	stomach
44	chr8:1910600-1911000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
45	chr8:1910600-1911600	Enhancers	Lung	lung
46	chr8:1910600-1912200	Enhancers	Brain Anterior Caudate	brain
47	chr8:1910600-1912200	Enhancers	Brain Hippocampus Middle	brain
48	chr8:1910600-1912200	Enhancers	Brain Inferior Temporal Lobe	brain
49	chr8:1910600-1912400	Enhancers	Brain Cingulate Gyrus	brain
50	chr8:1910800-1911000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links